DCGO Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -5.33%, SMA50 -14.41%, SMA200 -42.36%). The stock’s 14-day RSI is 39.91 (weak momentum), while the ATR of 0.06 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -83.58% below its high and over 7.78% above its low. Average 10-day trading volume of 707.86 thousand shares is below the 3-month average of 1.04 million, indicating normal recent market interest.

DocGo Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.84. This means the shares are trading below this model’s fair value.

DocGo Inc. (NASDAQ:DCGO) closed at $0.71 USD, losing -$0.01 (-1.67%) from the previous close of $0.72. The stock is currently mid-range between its 52-week high and low $0.49 and $2.45. With a market capitalization of about $69.85 million, DocGo Inc. is classified as a micro-cap and shows market-like volatility (beta ~0.98). Key stats such as the average daily volume over the past year has been around 1.06 million shares, volume is running light vs its 52-week average. Headquartered in New York City, NY, DocGo Inc. operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Lee Bienstock, the company employs approximately 3,404 people and listed since December 17, 2020. DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom.

The latest quarter delivered EPS of -$490,092.86. The next quarter is forecast at -$0.14. Next year's EPS is expected at $181.94. Analyst sentiment is neutral. Analyst rating data shows there are 1 Strong Buy ratings, 2 Buy ratings, 3 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $3.00 to $1.00. The high target offers 322.54% upside. The low target suggests 40.85% downside. The mean target is $2.10. This offers 195.77% upside. DocGo Inc. earnings surprise history is a mixed track record. The quarter that ended November 10, 2025, missed forecasts by 544547527.56%. The prior quarter beat by 83.33%. Over the last six quarters, Apple has recorded several small beats. These include -14.29% in August 07, 2024.

DocGo Inc. has 97.81 million shares outstanding. The public float is 85.70 million shares, elevated short interest at 4.22% of float. This equals 4.04 million shares. The short ratio is 8.07 days. Institutional investors hold 56.44% of the float. Insiders own 7.19%. Bienstock Lee holds 1.97 million shares, Oberholzer Adriaan Stephanus has 1.11 million shares and ROSENBERG NORMAN has 871.27 thousand shares. Over the past six months, insider transactions show net selling. They sold 16.85 thousand shares across 1 transactions.

DocGo Inc. trades at a P/E ratio of -0.38, slightly below the S&P 500 average, with a price-to-sales ratio of 0.22 and a price-to-book ratio of 0.48 suggesting the stock is closer to book value. The P/FCF stands at 2.58, also above market averages.

DocGo Inc. (NASDAQ:DCGO) shares are flat -7.47% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows DocGo Inc. trading at a premium to the broader market with a P/E of -0.38. Analyst sentiment is mixed, with the majority of ratings in Hold territory and a mean price target of $8.78, suggesting 1141.69% upside. Our AI forecast model points to short-term weakness (-1.0% over two weeks), a medium-term fall (-2.42% over three months), and a longer-term loss (-17.97% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that DocGo Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -1.0%, with price expected at $0.70 by May 12, 2026, within a range of $0.62 to $0.77 3-Month Outlook: Projected fall of -2.42%, reaching $0.69 by July 27, 2026, with a range of $0.60 to $0.75. 1-Year Outlook: Projected loss of -17.97%, with price at $0.58 by April 28, 2027, within a range of $0.00 to $0.00.